SCHEMBL7154241

SCHEMBL7154241

CC1=C(C(=O)O)C(C)(c2ccccc2Cl)C(C(=O)O)=C(COCCN)N1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.38
ADRA2A P08913 2/20 0.38
CHRM1 P11229 2/20 0.38
DRD1 P21728 2/20 0.38
TBXA2R P21731 2/20 0.38
SLC6A2 P23975 2/20 0.38
ADRA1A P35348 2/20 0.38
OPRM1 P35372 2/20 0.38
DRD3 P35462 2/20 0.38
SLC6A3 Q01959 2/20 0.38
KCNH2 Q12809 2/20 0.38
KCNK2 O95069 1/20 0.38
ABCB11 O95342 1/20 0.38
ADRB2 P07550 1/20 0.38
ABCB1 P08183 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADRB3 P13945 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA2C P18825 1/20 0.38
HRH2 P25021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656597 0.88 HTR1A (0.39) HTR1AADRA2ACHRM1DRD1TBXA2R
SCHEMBL6825360 0.85 HTR1A (0.37) HTR1AADRA2ACHRM1DRD1TBXA2R
SCHEMBL30516327 0.78 PYGL (0.34) HTR1AADRA2ACHRM1DRD1TBXA2R
SCHEMBL30516330 0.74 PYGL (0.32)
SCHEMBL30516333 0.74 PYGL (0.32)
SCHEMBL3393583 0.71 TSHR (0.40) HTR1AADRA2AADRA1AADORA3DRD2
SCHEMBL3027396 0.70 TSHR (0.43) CYP3A4KDM4EGAACYP2C9ALOX12
SCHEMBL29136595 0.68 HTR1A (0.35) HTR1AADRA2ACHRM1DRD1TBXA2R
SCHEMBL19687545 0.67 TBXA2R (0.66) HTR1AADRA2ACHRM1DRD1TBXA2R
SCHEMBL4757323 0.67 SMN1; SMN2 (0.40) SLC6A3KDM4ECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003101965-A1 TWO CRYSTALLINE HYDRATE FORMS OF AMLODIPINE BENZENESULFONATE OF HIGH PURITY, PROCESSES FOR THEIR PREPARATION AND USE LEK PHARMACEUTICALS D.D. (SI) 2003-12-11 WO disclosed